MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1111/1756-185x.14681

Медицинская библиотека · International journal of rheumatic diseases · 2023

Treatment for macrophage activation syndrome associated with systemic juvenile idiopathic arthritis in Japan.

Shimizu Masaki, Nishimura Kenichi, Iwata Naomi, Yasumi Takahiro, Umebayashi Hiroaki, Nakagishi Yasuo, Okura Yuka, Okamoto Nami, Kinjo Noriko, Mizuta Mao, Yashiro Masato, Yasumura Junko, Wakiguchi Hiroyuki, Kubota Tomohiro, Mouri Mariko, Kaneko Utako, Mori Masaaki

Многоцентровое исследованиеСтатьяПеревод в очереди

Аннотация

OBJECTIVES

To clarify how pediatric rheumatologists treat systemic juvenile idiopathic arthritis (s-JIA) associated macrophage activation syndrome (MAS) in the real world and to assess the efficacy and safety of dexamethasone palmitate (DEX-P) in the treatment of s-JIA-associated MAS.

METHODS

This multicenter, retrospective study was conducted at 13 pediatric rheumatology institutes in Japan. This study included 28 patients with s-JIA-associated MAS. Clinical findings, such as treatment details and adverse events, were evaluated.

RESULTS

Methylprednisolone (mPSL) pulse therapy was selected as the first-line treatment in more than half of the patients with MAS. Cyclosporine A (CsA) was used as first-line therapy in combination with corticosteroids in half of the patients with MAS. DEX-P and/or CsA were selected as the second-line therapy in 63% of patients with corticosteroid-resistant MAS. Plasma exchange was selected as the third-line therapy for DEX-P and CsA-resistant MAS. All patients improved and there were no characteristically severe adverse events associated with DEX-P.

CONCLUSIONS

The first-line treatment for MAS in Japan is mPSL pulse therapy and/or CyA. DEX-P could be an effective and safe therapeutic option for patients with corticosteroid-resistant MAS.

Для цитирования: Shimizu Masaki, Nishimura Kenichi, Iwata Naomi, Yasumi Takahiro, Umebayashi Hiroaki, Nakagishi Yasuo, Okura Yuka, Okamoto Nami, Kinjo Noriko, Mizuta Mao, Yashiro Masato, Yasumura Junko, Wakiguchi Hiroyuki, Kubota Tomohiro, Mouri Mariko, Kaneko Utako, Mori Masaaki. Treatment for macrophage activation syndrome associated with systemic juvenile idiopathic arthritis in Japan.. International journal of rheumatic diseases. 2023. DOI: 10.1111/1756-185x.14681.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.